
|Articles|August 20, 2012
Considerations for the Development and Manufacturing of Biosimilars [Presentation]
Advertisement
This content is provided by Amgen.
Divided into 3 sections, this presentation provides insight into the complexities of developing and manufacturing biologics and discusses considerations for the development of biosimilars.
Please click the image below to view the presentation.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM
2
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
3
Multiagonists Outpace Older GLP-1 Drugs for Weight Loss
4
Cardiac Risks of COVID-19 Vaccine vs Infection: Eman Toraih, MD, PhD
5




